InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Ondrey Aaron. Officer active across 2 companies, notably Mirati Therapeutics, Inc.. Cumulatively, 7 disclosures have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €40k. History available since 8 September 2023. The latest transaction was disclosed on 3 July 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Ondrey Aaron is Chief Financial Officer at Rocket Pharmaceuticals, INC. and Mirati Therapeutics, Inc. He has 7 filings in total, and across the 7 recent filings tracked, sales amount to EUR 39516 between 2023-09-12 and 2025-07-08.